Does IPV Boost Intestinal Immunity among Children under Five Years of Age? An Experience from Pakistan.

IPV OPV Pakistan Polio humeral immunity intestinal immunity

Journal

Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355

Informations de publication

Date de publication:
01 Sep 2023
Historique:
received: 18 07 2023
revised: 28 08 2023
accepted: 30 08 2023
medline: 28 9 2023
pubmed: 28 9 2023
entrez: 28 9 2023
Statut: epublish

Résumé

The oral poliovirus vaccine (OPV) has been the mainstay of polio eradication, especially in low-income countries, and its use has eliminated wild poliovirus type 2. However, the inactivated poliovirus vaccine (IPV) is safer than OPV, as IPV protects against paralytic poliomyelitis without producing adverse reactions. The present study compared mucosal and humoral responses to poliovirus vaccines administered to previously OPV-immunized children to assess the immunity gap in children in areas of high poliovirus transmission. A cluster-randomized trial was implemented in three high-risk districts of Pakistan-Karachi, Kashmore, and Bajaur-from June 2013 to May 2014. This trial was community-oriented and included three arms, focusing on healthy children below five years of age. The study involved the randomization of 387 clusters, of which 360 were included in the final analysis. The control arm (A) received the routine polio program bivalent poliovirus vaccine (bOPV). The second arm (B) received additional interventions, including health camps providing routine vaccinations and preventive maternal and child health services. In addition to the interventions in arm B, the third arm (C) was also provided with IPV. Blood and stool samples were gathered from children to evaluate humoral and intestinal immunity. The highest levels of poliovirus type 1 serum antibodies were observed in Group C (IPV + OPV). The titers for poliovirus type 2 (P2) and poliovirus type 3 (P3) were noticeably higher in those who had received a routine OPV dose than in those who had not across all study groups and visits. Providing an IPV booster after at least two OPV doses could potentially fill immunity gaps in regions where OPV does not show high efficacy. However, IPV only marginally enhances humoral immunity and fails to offer intestinal immunity, which is critical to stop the infection and spread of live poliovirus in populations that have not been exposed before.

Identifiants

pubmed: 37766121
pii: vaccines11091444
doi: 10.3390/vaccines11091444
pmc: PMC10534550
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Bill & Melinda Gates Foundation
ID : INV OPP1211074
Pays : United States

Références

Lancet Infect Dis. 2016 Dec;16(12):1310-1311
pubmed: 27638358
J Biol Stand. 1984 Jan;12(1):1-10
pubmed: 6699021
Expert Rev Vaccines. 2015;14(8):1113-23
pubmed: 26159938
Am J Epidemiol. 1972 Oct;96(4):263-9
pubmed: 4342327
J Infect Dis. 2018 Jan 17;217(3):371-380
pubmed: 29304199
Science. 2006 Nov 17;314(5802):1150-3
pubmed: 17110580
Lancet Infect Dis. 2016 Dec;16(12):1377-1384
pubmed: 27638357
J Infect Dis. 2018 Jan 17;217(3):344-346
pubmed: 29304197
Rev Infect Dis. 1991 Sep-Oct;13(5):926-39
pubmed: 1660184
MMWR Morb Mortal Wkly Rep. 2022 Oct 21;71(42):1313-1318
pubmed: 36264783
N Engl J Med. 2000 Sep 14;343(11):767-73
pubmed: 10984564
PLoS Pathog. 2012;8(4):e1002599
pubmed: 22532797
MMWR Morb Mortal Wkly Rep. 2020 Nov 20;69(46):1748-1752
pubmed: 33211676
J Infect Dis. 1991 Jan;163(1):1-6
pubmed: 1845806
MMWR Morb Mortal Wkly Rep. 2011 Nov 11;60(44):1523-7
pubmed: 22071591
Lancet. 1988 Apr 23;1(8591):897-9
pubmed: 2895828
J Infect Dis. 2014 Nov 1;210 Suppl 1:S152-61
pubmed: 25316830
Vaccine. 2015 Nov 27;33(48):6816-22
pubmed: 26476367
Vaccine. 2016 Jul 19;34(33):3803-9
pubmed: 27269054
Lancet. 2014 Oct 25;384(9953):1505-12
pubmed: 25018120
Lancet. 2016 Jul 9;388(10040):158-69
pubmed: 27212429
Lancet Infect Dis. 2019 Oct;19(10):1121-1128
pubmed: 31350192
Lancet. 2010 Nov 13;376(9753):1682-8
pubmed: 20980048
Curr Opin Virol. 2013 Jun;3(3):309-15
pubmed: 23759252
Euro Surveill. 2013 Sep 19;18(38):
pubmed: 24084337
Euro Surveill. 2014 Feb 20;19(7):20709
pubmed: 24576471
J Infect Dis. 2017 Feb 15;215(4):529-536
pubmed: 28003352
J Infect Dis. 2012 May 15;205(10):1554-61
pubmed: 22448007
Lancet Glob Health. 2017 Jun;5(6):e593-e603
pubmed: 28495264
J Infect Dis. 2014 Nov 1;210 Suppl 1:S380-9
pubmed: 25316859
Annu Rev Microbiol. 2005;59:587-635
pubmed: 16153180
Lancet Infect Dis. 2015 Aug;15(8):898-904
pubmed: 26093980
N Engl J Med. 1968 Oct 24;279(17):893-900
pubmed: 20617594
Future Microbiol. 2015;10(5):791-808
pubmed: 25824845
Lancet Infect Dis. 2016 Mar;16(3):321-30
pubmed: 26719058
MMWR Morb Mortal Wkly Rep. 2018 May 11;67(18):524-528
pubmed: 29746452
J Immunol. 1999 Apr 15;162(8):5011-8
pubmed: 10202050
Lancet Infect Dis. 2015 Nov;15(11):1273-82
pubmed: 26318714
Vaccine. 2017 Dec 19;35(52):7283-7291
pubmed: 29150209
Int J Infect Dis. 2014 Jan;18:4-13
pubmed: 24246740
J Infect Dis. 2018 Nov 5;218(12):1876-1882
pubmed: 29982532
Lancet. 2015 Dec 12;386(10011):2413-21
pubmed: 26388534
Vaccine. 2022 Apr 26;40(19):2705-2713
pubmed: 35367069
N Engl J Med. 2007 Apr 12;356(15):1536-44
pubmed: 17429085
MMWR Morb Mortal Wkly Rep. 2021 Oct 01;70(39):1359-1364
pubmed: 34591827
Vaccine. 2015 Jun 4;33(24):2757-63
pubmed: 25917673
Science. 2014 Aug 22;345(6199):922-5
pubmed: 25146288

Auteurs

Muhammad Atif Habib (MA)

Centre of Excellence in Women and Child Health, Aga Khan University, Karachi 74800, Pakistan.

Sajid Bashir Soofi (SB)

Centre of Excellence in Women and Child Health, Aga Khan University, Karachi 74800, Pakistan.
Department of Pediatrics & Child Health, Aga Khan University, Karachi 74800, Pakistan.

Imtiaz Hussain (I)

Centre of Excellence in Women and Child Health, Aga Khan University, Karachi 74800, Pakistan.

Imran Ahmed (I)

Centre of Excellence in Women and Child Health, Aga Khan University, Karachi 74800, Pakistan.

Zamir Hussain (Z)

Trust for Vaccines and Immunization, Karachi 74400, Pakistan.

Rehman Tahir (R)

Trust for Vaccines and Immunization, Karachi 74400, Pakistan.

Saeed Anwar (S)

Prime Institute of Public Health, Peshawar 25160, Pakistan.

Simon Cousens (S)

London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.

Zulfiqar A Bhutta (ZA)

Centre of Excellence in Women and Child Health, Aga Khan University, Karachi 74800, Pakistan.
Centre for Global Child Health, The Hospital for Sick Children, Toronto, ON M5G 1X8, Canada.

Classifications MeSH